BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22203494)

  • 1. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
    Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
    Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
    Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cancer stem cell markers in breast phyllodes tumor.
    Kim SI; Koo JS
    Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    Cha YJ; Koo JS
    PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of phyllodes tumor recurrence according to the histologic grade.
    Kim S; Kim JY; Kim DH; Jung WH; Koo JS
    Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
    Lei T; Yin L; Zhang H; Wei B; Chen H; Pu T; Yang L; Ye F; Zhang Z; Bu H
    Int J Clin Oncol; 2020 Dec; 25(12):2025-2034. PubMed ID: 32803488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
    Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
    Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Yes-associated protein (YAP) in breast phyllodes tumor.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(9):5997-6005. PubMed ID: 25337244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
    Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
    Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.
    Kim HM; Lee YK; Koo JS
    Dis Markers; 2016; 2016():4218989. PubMed ID: 27881889
    [No Abstract]   [Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis.
    Ahmed SS; Lim JCT; Thike AA; Iqbal J; Tan PH
    J Clin Pathol; 2022 May; 75(5):316-323. PubMed ID: 33627375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of succinate dehydrogenase in breast phyllodes tumor.
    Choi J; Kim DH; Jung W; Koo JS
    Histol Histopathol; 2014 Oct; 29(10):1343-54. PubMed ID: 24807638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.
    Kim S; Jung WH; Koo JS
    Tumour Biol; 2013 Oct; 34(5):2683-9. PubMed ID: 23636801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
    Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.
    Kucuk U; Bayol U; Pala EE; Cumurcu S
    Indian J Pathol Microbiol; 2013; 56(2):129-34. PubMed ID: 24056649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of lipid metabolism-related proteins in breast phyllodes tumors.
    Jung YY; Lee YK; Koo JS
    Neoplasma; 2016; 63(2):254-62. PubMed ID: 26774147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.